Orofacial dystonia and cervical muscle tension are common and underrecognized features of benzodiazepine withdrawal and benzodiazepine-induced neurological dysfunction (BIND). Patients present with persistent jaw clenching, bruxism, neck stiffness, pulling sensations in the cervical and paraspinal muscles, and in some cases frank dystonic posturing. The patient who arrives at a dental or oromaxillofacial specialist is frequently diagnosed with temporomandibular disorder (TMD), fitted with a bite splint, referred for physical therapy, and prescribed an NSAID. When none of these interventions produces meaningful relief, the patient is often told the condition is “chronic” or that stress is the cause.
The underlying issue in this clinical pattern is that the motor phenomena in question are neurologic, not musculoskeletal. TMD can certainly coexist with withdrawal-related dystonia, and the TMD interventions may reduce some of the secondary soft-tissue consequences, but the primary driver is in the central nervous system and the primary treatment is the management of the underlying withdrawal syndrome.
Why Dystonic Features Emerge in Withdrawal
The motor circuitry of the basal ganglia is extensively GABAergic. The direct and indirect pathways through the striatum depend on GABAergic inhibition at several synaptic levels, and the final output from internal globus pallidus and substantia nigra pars reticulata is itself GABAergic. Chronic benzodiazepine exposure modulates these circuits through GABA-A receptor effects, and the removal of that modulation during and after a taper can produce motor phenomena that reflect the altered balance.
The clinical expressions include tremor (most familiar), myoclonus, dystonia (sustained or intermittent abnormal postures), akathisia-like inner restlessness, and increased muscle tone. The orofacial region — with its dense motor innervation and its susceptibility to dystonic expression in other contexts (dopamine-blocking medications, Wilson disease, tardive syndromes) — is a frequent site of manifestation.
Cervical dystonia and paraspinal muscle tension follow the same mechanism. The involuntary sustained contraction of cervical muscles can be severe enough to produce head tilt, pulling sensations, and secondary pain that the patient interprets as orthopedic.
What the Presentation Looks Like
Several features characterize withdrawal-related orofacial and cervical dystonia.
Persistent clenching and bruxism. Jaw muscles in sustained tension during the day, often worse at specific times (morning, stress), with secondary muscle soreness and headache. Nocturnal bruxism that may or may not have been present before the taper can intensify.
Bilateral involvement. Withdrawal-related features tend to be bilateral, affecting both masseters, both temporalis, and both cervical paraspinal groups. Unilateral TMD from joint pathology typically asymmetric.
Normal imaging and joint examination. Temporomandibular joint imaging is typically unremarkable. Disc position, joint space, and articular surface are not abnormal. Range of motion may be reduced secondary to muscle tension but the joint itself is not the driver.
Resistance to standard TMD treatment. Bite splints may reduce bruxism-related tooth wear and some secondary soreness, but they do not address the central driver. Physical therapy focused on the joint and surrounding musculature gives limited and temporary relief.
Time-locking to dose changes. Intensity often increases after benzodiazepine reductions and improves with dose holds, which is diagnostic when observed.
Accompanying broader movement phenomena. Tremor, myoclonic jerks, muscle twitches elsewhere, and inner restlessness are frequently present. A patient with orofacial tension in isolation is less clearly in the withdrawal category than a patient with orofacial tension plus multiple other movement features.
Pulling and tugging sensations. A subjective sense of the muscles being “pulled” in ways the patient cannot control, often described as different from the experience of muscle soreness.
How the Diagnostic Error Happens
The patient presents to a dentist or TMD specialist because the symptoms feel jaw-related. The evaluating clinician works from a TMD framework, orders appropriate TMD imaging, finds nothing structurally abnormal, and fits the patient into a category of “muscular” TMD. The conversation about the benzodiazepine taper typically does not happen, either because the patient does not raise it or because the specialist does not consider pharmacologic causes within their differential.
Referral to neurology, when it happens, can produce a more accurate assessment — but only if the neurologist is familiar with withdrawal-related movement phenomena. A neurologist who sees no structural lesion on imaging and no epileptiform activity on EEG may return the patient to the primary clinician with “functional movement disorder,” which is the same labeling problem that BIND patients frequently encounter.
Management Within a Withdrawal Framework
Several interventions are useful, and several commonly-used TMD and dystonia treatments need specific care in this population.
Slower taper pace. The primary intervention. If the features are time-locked to dose reductions, slowing the schedule or holding the dose during exacerbations produces the most reliable improvement.
Heat and gentle stretching. Low-intensity physical interventions can reduce secondary muscle soreness without producing the flare that more aggressive physical therapy sometimes triggers in BIND patients.
Botulinum toxin injections for severe dystonia. Focal injections into overactive muscles (masseter, temporalis, cervical muscles) can provide symptomatic relief for dystonia that is disabling. The intervention does not treat the underlying cause but reduces the burden while recovery proceeds. Effects last three to four months.
Bite splints. Appropriate for the prevention of dental damage from bruxism. Not expected to resolve the underlying tension.
Caution with muscle relaxants. Cyclobenzaprine and carisoprodol have sedating and anticholinergic effects that complicate the withdrawal picture. Tizanidine and baclofen are used for spasticity and have alpha-2 and GABA-B effects respectively that can help some patients; both can produce their own withdrawal phenomena and should be used with care and time-limited duration.
Avoid typical antipsychotics and metoclopramide. Dopamine-blocking agents can produce or worsen dystonic features and carry long-term risks of tardive syndromes in a nervous system that is already pharmacologically destabilized. These should be avoided unless an overriding indication exists.
Avoid “as-needed” benzodiazepine use for symptom flares. Intermittent benzodiazepine dosing in a patient already tapering or recently off produces rebound when the dose wears off and can destabilize the taper. Reinstatement to a stable daily dose — if clinically indicated — is different from intermittent symptom-driven use, which is generally counterproductive.
Magnesium and basic nutritional support. Magnesium deficiency can contribute to muscle symptoms. Supplementation is low-risk and occasionally helpful.
What to Ask For at the Workup
For a patient with jaw and neck tension in the context of a benzodiazepine taper who is being evaluated for TMD, several requests shift the clinical framing in a useful direction.
Request that the benzodiazepine history be explicitly recorded in the TMD workup. A bite splint fitted in a chart that does not mention the benzodiazepine is less useful than one fitted in a chart that frames the splint as adjunctive to withdrawal management.
Ask whether the clinical picture could reflect dystonic features rather than primary TMD. Even if the answer is “I’m not sure,” raising the question often changes what interventions the specialist offers and whether neurology consultation is considered.
Request neurology consultation if the picture includes features beyond isolated jaw and neck tension — tremor, myoclonus, other movement phenomena — with a specific question about withdrawal-related movement features. A neurologist familiar with BIND will frame the picture accordingly; one who is not may still be useful for excluding other movement disorder etiologies.
Jaw tension and cervical dystonia in benzodiazepine withdrawal are not TMD misdiagnosed. They are neurologic manifestations of a withdrawal syndrome that the TMD framework was not designed to capture. Recognizing this changes what interventions help, what expectations are reasonable, and how the patient’s trajectory aligns with the underlying recovery.